automated lab

R&D

Automation holds the potential to enhance scientific rigour and operational efficiency while solving long-standing regulatory conundrums.

News

In its third big licensing deal of the week, Eli Lilly has tapped RNA-editing specialist Ascidian for kidney disease therapies in a $1.9bn alliance.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.